Seeking Alpha · 28 Oct 2026, 15:21 UTCSK hynix: Don't Panic Over The Immediate Threat Of CXMT's 4F Squared Efforts (NASDAQ:SKHY) | Seeking AlphaASML2.5% of DFSI
Seeking Alpha · 28 Oct 2026, 07:02 UTCASML: Exceptional Semiconductor Business, Expensive Valuation (NASDAQ:ASML) | Seeking AlphaASML2.5% of DFSI
wallstreet:online · 28 Oct 2026, 19:55 UTCTD Announces Appointment of Amit Sahasrabudhe as U.S. Chief Operating OfficerRoyal Bank of CanadaRYThe Toronto-Dominion BankTD1.3% of DFSI
Seeking Alpha · 28 Oct 2026, 18:55 UTCRoche: Valuation Leaves Limited Upside (OTCMKTS:RHHBF) | Seeking AlphaRoche Holding1.3% of DFSI
Seeking Alpha · 27 Oct 2026, 19:00 UTCTech Bubble Will Pop In 2027 (undefined:ANT) | Seeking AlphaASML2.5% of DFSI
London South East · 28 Oct 2026, 11:23 UTCWRAPUP 2-European banks beat profit forecasts, Brazil overshadows SantanderHsbc HoldingsBnp ParibasBNPQFStandard CharteredSCBFFUBS GroupUBS1.5% of DFSI
24/7 Wall St. · 27 Oct 2026, 16:46 UTCASML's $812 Million Dividend: What Shareholders Collect on Nov. 4ASML2.5% of DFSI
The Financial Express · 28 Oct 2026, 06:25 UTC5 Power Equipment Stocks to WatchAbbABBNSiemensHitachiHCHMF1.6% of DFSI
London South East · 28 Oct 2026, 08:18 UTCWRAPUP 1-European banks beat forecasts with third-quarter profitHsbc HoldingsBnp ParibasBNPQFStandard CharteredSCBFFUBS GroupUBS1.5% of DFSI
wallstreet:online · 28 Oct 2026, 14:05 UTCSandoz reports strong biosimilar-sales momentum; narrowed full-year net-sales range and upgrade to margin guidanceNovartisNVS1.1% of DFSI
wallstreet:online · 28 Oct 2026, 06:05 UTCDKSH Expands its Healthcare Own Brands Portfolio With the Acquisition of Rocephin From RocheRoche HoldingDksh Holding1.3% of DFSI
Seeking Alpha · 28 Oct 2026, 12:00 UTCSandoz Group AG (SDZNY) Q3 2026 Sales/Trading Call Transcript | Seeking AlphaNovartisNVS1.1% of DFSI
The Straits Times · 28 Oct 2026, 09:19 UTCMajor European banks beat third-quarter profit forecastsHsbc HoldingsBnp ParibasBNPQFUBS GroupUBS1.2% of DFSI
The Manila times · 28 Oct 2026, 06:07 UTCRoche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesotheliomaRoche Holding1.3% of DFSI
The Manila times · 28 Oct 2026, 11:10 UTCMonte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)NovartisNVS1.1% of DFSI
The Wall Street Journal · 28 Oct 2026, 09:49 UTCSandoz Shares Fall After Company Turns Cautious on Sales GuidanceNovartisNVS1.1% of DFSI
Investing.com · 28 Oct 2026, 09:35 UTCEarnings call transcript: Sandoz narrows 2026 sales view after strong Q3 By Investing.comNovartisNVS1.1% of DFSI
Bloomberg Business · 28 Oct 2026, 09:34 UTCSandoz Warns EU May Scrap Antibiotic Protection, Risking PlantNovartisNVS1.1% of DFSI
Global News · 28 Oct 2026, 19:59 UTCAI agents banned by several of Canada's biggest banks as fears growRoyal Bank of CanadaRY0.8% of DFSI